Publications:55
David J Mulholland, PhD
About Me
Language
English
Position
ASSOCIATE PROFESSOR | Oncological Sciences
Publications
Selected Publications
- Tumor-Infiltrating Myeloid Cells Confer De Novo Resistance to PD-L1 Blockade through EMT–Stromal and Tgfb-Dependent Mechanisms. Haocheng Yu, John P. Sfakianos, Li Wang, Yang Hu, Jorge Daza, Matthew D. Galsky, Harkirat S. Sandhu, Olivier Elemento, Bishoy M. Faltas, Adam M. Farkas, Nina Bhardwaj, Jun Zhu, David J. Mulholland. Molecular Cancer Therapeutics
- Dynamic plasticity of prostate cancer intermediate cells during androgen receptor-targeted therapy. Harkirat S. Sandhu, Kensey L. Portman, Xianxiao Zhou, Julia Zhao, Alexander Rialdi, John P. Sfakianos, Ernesto Guccione, Natasha Kyprianou, Bin Zhang, David J. Mulholland. Cell Reports
- Global DNA methylation of WTC prostate cancer tissues show signature differences compared to non-exposed cases. Haocheng Yu, Stephanie Tuminello, Naomi Alpert, Maaike Van Gerwen, Seungyeul Yoo, David J. Mulholland, Stuart A. Aaronson, Michael Donovan, William K. Oh, Yixuan Gong, Li Wang, Jun Zhu, Emanuela Taioli. Carcinogenesis
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Mulholland has not yet completed reporting of industry relationships or has no industry relationships to report.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.